Mr. Andrews introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.
5 U.S.C. 553 15 U.S.C. 1, 12, 45
and
56 21 U.S.C. 355
and
355 221 U.S.C. 355(j)
Document Citations
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Drug Competition Act of 2001. H.R. 1063. 107th
Cong., 1st
sess., Introduced in House March 15, 2001. https://www.govinfo.gov/app/details/BILLS-107hr1063ih.
APA
Congress, House of Representatives (2001, March 15). Drug Competition Act of 2001 (H.R. 1063 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-107hr1063ih.
MLA
United States, Congress, House of Representatives. Drug Competition Act of 2001. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-107hr1063ih. 107th Congress, H.R. 1063, Introduced in House 15 Mar. 2001.
Bluebook
H.R.1063 - 107th Congress (2001-2002): Drug Competition Act of 2001, H.R.1063, 107th Cong. (2001), https://www.govinfo.gov/app/details/BILLS-107hr1063ih.
